chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient states oln 4/26/2021 about 1 week after her vaccination, she had a swollen throat and her neck felt bigger but it did not affect her breathing.   On 5/3/21 she noticed chest pain that lasted till 5/7/2021.  She did not call pharmacy or report her symptoms until she came to receive her second Pfizer Covid-19 vaccination on 5/11/2021.   She stated that she did not contact her doctor and that she still wanted to take the 2nd covid vaccination.   The patient received her injection and left without and reaction.
Patient reported to the pharmacy 10/19/19 to report swelling, tenderness, and redness at the site of administration. It appeared to spread from shoulder down to elbow. I told the patient it appeared to be in the realm of a normal reaction to me, as it had no system effects, no issues with range of motion or ability use arm/arm function. I told the patient if the swelling became uncomfortable to let us know (it was not at this point) and if the affected area spread to let us know, and if there was any issues with the use of the arm to inform us and seek medical advise from a physician.
After adm. of vaccine pt. body became rigid and jerking. Eyes open with complete dilation of pupils. Episode lasted a few seconds. Pt then fainted for a few seconds Dr. entered room pt awake, hot, pale and nauseated. Took BP which was normal, gave crackers and Sprite. Pt well other than fatigue.
p/vax pt devel massive, red swelling @ the inj site & T102-104;massive was not defined;
Tinnitus that started  April 8 2021. The ringing in my ears does not stop since then.
1408 Numbness and tingling of bilateral cheeks and swelling of fingers. Denies SOB, dysphagia,cough,diziness,syncope,Vital 120/82,82,96%. Given  Benadryl 50mg  po. 1419 Reports symptoms calming down less sensation of swelling and calming down. 1433 spoke with husband and notified of situation. 1515 Patient exited in stable condition. Agreed and understands of what to do if symptoms worsen or continue.
Patient said he has been experience throbbing arm pain since the shot.  He said it's not at the injection site but feels like its deep in the bone. He says it affects his whole left arm.  At night it can seem worse.  He said it started the day he got the Arexvy shot.
dizzy/had crystals out of place in her right inner ear; could not get out of bed; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy/had crystals out of place in her right inner ear) and MOVEMENT DISORDER (could not get out of bed) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 010A21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: INFLUENZA VACCINE (A month prior to the Moderna shot she did receive a flu shot) in February 2021. Concurrent medical conditions included Blood pressure high. Concomitant products included CLONIDINE, LOSARTAN, ASPIRIN [ACETYLSALICYLIC ACID], HYDRALAZINE, TORSEMIDE, LABETALOL, ALLOPURINOL, ATORVASTATIN, NIFEDIPINE, VITAMIN D [VITAMIN D NOS] and VITAMIN B12 [VITAMIN B12 NOS] for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced DIZZINESS (dizzy/had crystals out of place in her right inner ear) and MOVEMENT DISORDER (could not get out of bed). On 05-Apr-2021, MOVEMENT DISORDER (could not get out of bed) outcome was unknown. In April 2021, DIZZINESS (dizzy/had crystals out of place in her right inner ear) outcome was unknown.            It was reported that the patient went to therapy once and wore a brace for 24 hours and was taught how to manipulate the head to help alleviate the symptoms if they should return.
This spontaneous case reported by a healthcare professional, describes the occurrence of product dose omission issue (missed 2nd dose) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 002C21A) for COVID-19 immunization. No medical history reported. On Apr 22, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced product dose omission issue (missed 2nd dose). At the time of the report, product dose omission issue (missed 2nd dose): resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information.
Narrative: Patient was found to be short of breath with heart rate in the 140s.  Initially he was thought to possibly be having an allergic reaction to the vaccine.  For this, he received prednisone, Benadryl and famotidine. These medications did  not improve his symptoms. He was then discovered to be in atrial flutter. He was  admitted to the ICU for close monitoring. There he remained hemodynamically  stable. He was treated with beta blockade that improved his heart rate and his  symptoms. He was discharged to home the following day.
Blurred vision; Shaking; Dizziness; BP 135/71 mmHg; Bad headache; Mind shutting down; This spontaneous case was received on 13-Sep-2022 from non-healthcare professional (consumer) via Communications (reference number: SEQW22-02941) and concerned a female patient of unreported age.   The patient's concurrent condition included unspecified allergies. The patient's concomitant medication included unspecified vitamins, used for an unreported indication.  On 10-Sep-2022, the patient was vaccinated with Flucelvax Quadrivalent (prefilled syringe) (influenza vaccine inact sag 4v; dose: 0.5 ml, route of administration: intramuscular and anatomical location: not reported) for prevention of influenza disease. The batch number was not reported.  On 11-Sep-2022, one day after receiving Flucelvax Quadrivalent, at night as reported, the patient experienced shaking, mind shutting down, bad headache, dizziness and blurred vision. The patient called emergency service 911 and they came. Vital signs were measured, there were no signs of stroke, no slurred speech or droopy sign. Blood analysis was done (blood was collected from finger), however results were not provided, oxygen level was 90 (units not provided), blood pressure (BP) was 135/71 mmHg.   On 12-Sep-2022, by the end of the day as reported, the patient recovered from all events as she felt normal.   The reporter did not provide a causality assessment.  The case was assessed as non-serious.  Company comment: A female patient of unreported age experienced tremor, vision blured, dizziness, blood pressure systolic increased, headache and feeling abnormal (reported as mind shutting down), one day after being vaccinated with the suspect Flucelvax Quadrivalent vaccine, at night as reported. Vital signs were measured, there were no signs of stroke and blood pressure was 135/71 mmHg. By the end of the next day, the patient recovered from all events. Based on plausible time relationship, causality is assessed as possibly related.; Sender's Comments: A female patient of unreported age experienced tremor, vision blured, dizziness, blood pressure systolic increased, headache and feeling abnormal (reported as mind shutting down), one day after being vaccinated with the suspect Flucelvax Quadrivalent vaccine, at night as reported. Vital signs were measured, there were no signs of stroke and blood pressure was 135/71 mmHg. By the end of the next day, the patient recovered from all events. Based on plausible time relationship, causality is assessed as possibly related.
she did all the Pfizer shots and boosters/ tested positive for COVID; she did all the Pfizer shots and boosters/ tested positive for COVID; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 85-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "she did all the Pfizer shots and boosters/ tested positive for COVID". The patient underwent the following laboratory tests and procedures: Oxygen saturation: 98, notes: my little finger in the air thing is 98; SARS-CoV-2 test: positive.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Substantial weakness, muscle aches and fatigue, chills, fever, headache, neuropathies, additional digestive problems. Recovered slowly over 5 days.
BEGAN FEELING FATIGUED AROUND 4PM YESTERDAY. WOKE UP THIS MORNING WITH BODY ACHES AND FATIGUED.
Fever; Chills; Achiness; Headache; Tenderness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-health care professional and Physician). The reporter is the patient. A 78-year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 05Feb2021 (Lot number: EL9264) at the age of 77 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Glucose intolerance" (ongoing); "Hypolipidemia" (ongoing), "Hypothyroid" (ongoing), "Acid reflux" (ongoing). Concomitant medication(s) included: BIOTIN, CHOLECALCIFEROL; GINGER [ZINGIBER OFFICINALE], LEVOTHYROXINE; METFORMIN, CALCIUM, VITAMIN D [VITAMIN D NOS]. Vaccination history included: Bnt162b2 (Dose: 1, Lot: EL0142, Anatomical site of Location: Left deltoid) administration date: 18Jan2021, when the patient was 77 years old for COVID-19 immunisation, reaction(s): "Tenderness". The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "Fever", CHILLS (non-serious), outcome "unknown", described as "Chills", PAIN (non-serious), outcome "unknown", described as "Achiness", HEADACHE (non-serious), outcome "unknown", described as "Headache", TENDERNESS (non-serious), outcome "unknown", described as "Tenderness". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Prior to vaccination, was the patient did not diagnosed with COVID-19.  Follow-up attempts are completed. No further information is expected.
After each dose within 24 hrs, thick,  inspissated mucous, coughing; after 3rd dose choked, cyanosis, required bulb suctioning. Paramedics called/not transported.
Tingling, painful, numb feet.  Painful shins, chills, sweaty,  nausea,  odd taste in mouth, very dry lips.  All started 4 days after inoculation, lasted 10 days.
This spontaneous report was received from a physician via regulatory authority. As from the beginning of the current school year (2014-2015) during the last month (October 2014), they have received to the Division of Epidemiology 4 reports of dizziness and pallor after vaccine administration in patients between the ages of 13-14 years. On an unknown date, the 4 patients were vaccinated with GARDASIL (lot # J016198 and expiration date was 30-MAY-2016, or lot# K007693, expiration date unspecified) (dose and route were not reported). On unknown dates the patients experienced dizziness and pallor. The outcome of events was unknown. Causality was not provided by agency. This is one of the several reports from the same source. Additional information has been requested.
Whole Arm was sore immediately after injection. Eventually I was unable to use my arm. Shoulder pain when moving my arm, unable to lift my arm, and sharp pain when sleeping and not even moving my arm. I went to the nurse's office at my place of work about a week after getting the shot at the school's clinic and she told me that it wasn't normal and to go see a doctor if it didn't go away. I finally couldn't take the pain anymore and I went to a clinic on 11/30. They prescribed ibuprofen and a muscle relaxer for 8 days. I did feel some relief but still unable to move my arm without pain. I went to my PCP on 12/14. She referred me to an orthopedic doctor and my visit is tomorrow 12/15.
Pt c/o unusual sensations, paresthesias & numbness of fingers within 48 hrs. Complete Neuro exam was negative. Referred to Neurology and tempory waiver.
Immediately following 1st dose of Rotateq patient developed cramping/fussiness then diarrhea that lasted about 2 weeks and sever diaper rash.
This spontaneous report as received from a licensed practical nurse refers to a 12 year old patient of unknown gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On 23-SEP-2015, the patient was vaccinated with a dose of improperly stored GARDASIL 9 (lot number L000610 and expiration date 31-JAN-2017) (dose and route of administration were not reported). Concomitant therapy was not reported. No adverse effects were reported. Additional information has been requested.
Expired vaccine, no adverse reactions. Expiration date 06/2023, vaccine administered 07/24/2023
Significant lip swelling, rash around and inside mouth, swelling roof of mouth, sensitivity inside mouth and throat, itching around outside mouth and chin, pressure behind face and neck, anal itching, pain, and swelling
toothache; This is a spontaneous report from a contactable consumer (patient himself). A 65-year-old male patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EL9263) via an unspecified route of administration on 27Jan2021 as 1st dose single (at the age of 65-years-old) for COVID-19 immunization. Patient medical history included an ongoing toothache. The concomitant medications included ibuprofen taken at dose in-between 400-600 mg 3 times a day for toothache. Patient reported that he took Ibuprofen for his toothache before and after vaccination. Patient said that he received his first shot yesterday (28Jan2021) and he has been bothered with a toothache the last couple days and will be bothered with it for a day or two until he can get the tooth extracted. He says he read that it was not recommended to take Ibuprofen prior to vaccination and after vaccination, which he did, so he would like to know what is the situation. He said he did not had any problems. The outcome of event was unknown.   Follow-up attempts are completed. No further information is expected.
This is a spontaneous report from a contactable consumer. A 64-year-old female patient received PREVNAR 13 (NDC# 0005-1971-02), via an unspecified route of administration, on 18May2017, at 0.5 ml single, for immunisation. PREVNAR 13 was not prescribed, patient took the vaccine for her own willing. Medical history included polycystic kidney (stage 1). Concomitant medications included VIIBRYD, potassium (unspecified trade name), hydrochlorothiazide (unspecified trade name), VITAMIN D. On an unspecified date the patient experienced vomiting constantly with outcome of recovering, shaking with outcome of unknown, freezing with outcome of unknown, chills with outcome of unknown, dizzy with outcome of unknown, muscle ache with outcome of not recovered, restlessness with outcome of not recovered, diarrhea with outcome of recovering. The patient visited the emergency room on 19May2017 and underwent lab tests and procedures which included lab work.
Anaphylactic reaction; choking; could not breathe; legs have been red; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for a female patient (wife). A female patient of an unspecified age received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and Expiration date were unknown) via an unspecified route of administration as single dose for COVID-19 immunisation. The reporter stated that the patient never had allergies, not until she took the Pfizer covid-19 vaccine. Concomitant medications were not reported.   On an unspecified date, the patient had an Anaphylactic reaction after first dose and started choking and could not breathe. The reporter also stated they gave her two shots in her legs of Adrenaline right after first dose of covid-19. The reporter then stated his wife went to the hospital and was prescribed medication which than gave her allergies and her legs have been red since taking medication. Treatment was received for the events, Anaphylactic reaction, started choking and could not breathe. The outcome of the events was unknown.
Patient given flu vaccine at 10 am 10/10/16. Developed hive over ankle at 5 pm 10/10/16. Hives progressed over the next 16 hours to cover face, trunk, limbs. Some hives were very large. They waxed and waned but totally resolved with BENADRYL. No SOB, wheeze, stridor, GI or pt changes.
Systemic: Confusion-Medium, Systemic: Dizziness/Lightheadedness-Medium, Systemic: Fainting/Unresponsive-Medium, Systemic: Seizure-Mild, Systemic: Tingling (specify: facial area, extremities)-Medium.
reported by phone by dad high pitched screaming x 4 days; started 2 hrs p/shots given; rash which looked like hives p/2 days (p/shots given);
Patient admitted for PE on 9/9/21 after presenting to ER w/3 day hx of chest wall pain and cough. Risk factors for VTE included: vague hx of clots in her father, use of birth control, and C section on 6/30/21. None of her attending providers included the covid vaccine as part of the differential/etiology of her PE; this is concerning from my perspective given that the patient got her first vaccine dose less than a month before the PE.
Noticed on 9/19 pain, swelling, redness, inflammation at injection site;  the area was a hard lump upon palpitation;  the area was initially at the injection site but it moved lower in the arm a day later 9/20; level of pain was the same on day of injection compared to 2nd day after injection.  Took Advil 1-2 times daily to relieve symptoms and it helped.  9/22 symptoms are better by half.
This is a spontaneous report from a contactable physician. A male patient of an unspecified age and ethnicity received PREVNAR 13, via an unspecified route of administration on an unspecified date at single dose for immunisation. Medical history included myasthenia gravis, chronic obstructive pulmonary and asthma, all from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced upper respiratory symptoms on an unspecified date after the vaccination. The patient was given antibiotics that did not improve his symptoms, so he was treated with steroids and his symptoms improved. The outcome of the event was recovering.
Vomiting/nausea, abdominal pain.  Has occurred daily since 8/14/11.  Severe headaches, fatigue, joint pain, orthostatic hypotension, orthostatic tachycardia.
Patient under age 18 was vaccinated with Moderna, which is a vaccine error, on 4/2/2021. He turned 18 prior to second vaccine. Troubleshooting: Scribe and vaccinator did not validate age;  screeners at the beginning of the process did not ask or turn away on a Moderna-only day. Unreported as error, found in data mining. Age restriction/confirmation rules were put into effect after the date of this vaccine to prevent underage vaccines.
Fever, fatigue, chills, arm soreness, body aches, joint pains, backache, headache.  24hr span treated with ibuprofen 400mg.
Pt vaccinated with DTP/OPV developed fever to 39.0 C (R), abnormal crying >3hrs.
bells palsy within 72 hrs on same side as injection; This is a spontaneous report from a contactable consumer reporting for self. This 48-year-old female patient received the second dose of bnt162b2 (Pfizer-Biontech COVID-19 vaccine) via an unspecified route of administration in left arm on 07May2021 02:00 PM (Lot Number: EW0168) at single dose for COVID-19 immunization. The patient is not pregnant. The patient's medical history was not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient's concomitant medications included OTC cetirizine hydrochloride (ZYRTEC) and fluticasone propionate (FLONASE). The patient had allergy to famotidine (PEPCID). The patient previously received the first dose of bnt162b2 (Pfizer-Biontech COVID-19 vaccine) via an unspecified route of administration in left arm on 16Apr2021 01:15 PM (Lot Number: ER8731) at single dose for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced bells palsy within 72 hours on same side as injection. The event start date was reported as 09May2021. The event resulted in doctor or other healthcare professional office/clinic visit. The events were reported as non-serious. The patient was tested nasal swab (Abbott Binax) on 17May2021 with negative result. The patient received prednisone and valacyclovir as treatment. The outcome of event was recovering.
On 10/6/99, the pt experienced joint pain and swelling which had progressed until notification of the MD on 10/11/99. The pt also experienced general malaise. Prednisone was prescribed. Follow up states as of 2-Nov-99, the patient was still ill but better. Reportedly the patient recovered from this experience.
Developed rash on my hands after receiving the second Pfizer shot for COVID.  Rash will not go away.
Patient was in exam room which was warm. She had a vasovagal response when getting up to leave her appointment. She was evaluated by MD and given oral hydration. Patient left office in good standing.
As a patient with Asthma, Aspirin is a medicine that makes me short of breath. I do not think it is an allergy as such, but a hypersensitivity to Acetylsalysilic Acid. 1 hour after the application of the vaccine, I felt the same symptoms as when I used any component that contains acetylsalysilic acid. In those cases I must apply inhaler. So I did, in 1 hour, I was already better. I didn't need to go to a doctor or hospital.